Elsevier

Medicina Clínica

Volume 146, Issue 10, 20 May 2016, Pages e57-e58
Medicina Clínica

Carta al Editor
Rabdomiólisis yatrógena en un paciente con cardiopatía isquémicaIatrogenic rhabdomyolysis in a patient with ischemic heart disease

https://doi.org/10.1016/j.medcli.2015.11.032Get rights and content

Bibliografía (10)

There are more references available in the full text version of this article.

Cited by (3)

  • Development of an LC-MS/MS method for simultaneous determination of ticagrelor and its active metabolite during concomitant treatment with atorvastatin

    2019, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    Citation Excerpt :

    However, co-administration of TIC with other drugs might lead to life-threatening interactions. Recently, several cases have been reported of interaction between TIC and atorvastatin (AT), resulting in rhabdomyolysis [7–9]. Of note, the patients were elderly (>62 years of age) and the dose of AT was at least 40 mg per day.

View full text